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Background: Adhesion and migration are relevant physiological functions that must be regulated by the cell under
both normal and pathological conditions. The dioxin receptor (AhR) has emerged as a transcription factor
regulating both processes in mesenchymal, epithelial and endothelial cells. Indirect results suggest that AhR could
cooperate not only with additional transcription factors but also with membrane-associated proteins to drive such
processes.
Results: In this study, we have used immortalized and primary dermal fibroblasts from wild type (AhR+/+) and
AhR-null (AhR−/−) mice to show that AhR modulates membrane distribution and mobilization of caveolin-1
(Cav-1) during directional cell migration. AhR co-immunoprecipitated with Cav-1 and a fraction of both proteins
co-localized to detergent-resistant membrane microdomains (DRM). Consistent with a role of AhR in the process,
AhR−/− cells had a significant reduction in Cav-1 in DRMs. Moreover, high cell density reduced AhR nuclear levels and
moved Cav-1 from DRMs to the soluble membrane in AhR+/+ but not in AhR−/− cells. Tyrosine-14 phosphorylation
had a complex role in the mechanism since its upregulation reduced Cav-1 in DRMs in both AhR+/+ and AhR−/−cells,
despite the lower basal levels of Y14-Cav-1 in the null cells. Fluorescence recovery after photobleaching revealed that
AhR knock-down blocked Cav-1 transport to the plasma membrane, a deficit possibly influencing its depleted levels in
DRMs. Membrane distribution of Cav-1 in AhR-null fibroblasts correlated with higher levels of cholesterol and with
disrupted membrane microdomains, whereas addition of exogenous cholesterol changed the Cav-1 distribution of
AhR+/+ cells to the null phenotype. Consistently, higher cholesterol levels enhanced caveolae-dependent endocytosis
in AhR-null cells.
Conclusions: These results suggest that AhR modulates Cav-1 distribution in migrating cells through the control of
cholesterol-enriched membrane microdomains. Our study also supports the likely possibility of membrane-related,
transcription factor independent, functions of AhR.
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The aryl hydrocarbon Receptor (AhR)/Dioxin receptor is
a basic-helix-loop-helix (bHLH) transcription factor well
known for its relevant role in the cellular response to
carcinogens such as TCDD and benzo[a]pyrene [1,2].
Many studies over the last few years have also estab-
lished that AhR expression is required for normal cell
functioning and for the homeostasis of the hepatic, im-
mune, cardiovascular and reproductive systems [3,4].
Particularly interesting is the implication of AhR in
the control of cell adhesion and migration under normal
(e.g. xenobiotic-free) conditions. Previous work has
shown that the AhR-target gene Cyp1a1 is induced after
suspension of human keratinocytes, mouse Hepa1 cells
and 10T1/2 fibroblasts [5,6], suggesting that AhR is acti-
vated following the disruption of cell-cell and cell-
substratum interactions. In agreement, AhR knock-out
altered positioning and axon migration of neuronal cells
in the invertebrate C. elegans [7] and reduced migration
of murine fibroblasts [8-10] and endothelial cells [11].
Such migration-related functions of AhR can be induced
by TCDD in human hepatoma HepG2 [12] and human
breast tumor MCF-7 [13] cells or by receptor knock-out
in primary keratinocytes [14]. Taken together, these
studies emphasize that AhR is likely a novel molecular
intermediate in the signaling pathways controlling cell
adhesion and migration.
Under xenobiotic-free conditions, murine fibroblasts
lacking AhR (AhR−/−) develop an excess of F-actin
stress fibers and a significant increase in the number
and size of focal adhesions that compromise their migra-
tory and invasive potentials. These phenotypes are at
least partially due to the inefficient activation of focal ad-
hesion kinase and to an altered balance between Rac1
and RhoA activities, presumably consequence of the re-
duced expression of the AhR target gene Vav3 [10,15].
More recently, we have described that AhR also controls
cell adhesion and migration of mesenchymal fibroblasts
through the extracellular matrix protein fibronectin and
the membrane adaptor Cbp/Pag1 (Csk-binding protein)
[16]. This latter mechanism converges to the regulation
of β1-integrin and c-Src activities that ultimately con-
trols Cav-1 expression and phosphorylation [16]. Based
on this work, we proposed the existence of a pathway
connecting AhR with Cav-1 in the control of cell adhe-
sion and migration.
Cav-1 is one of the main components of the 60–80 nm
plasma membrane caveolae structures [17-19] involved in
the regulation of multiple cellular functions [20] and in
the progression of serious diseases such as cancer [21,22].
Importantly, Cav-1 is relevant in cell migration as mouse
embryonic fibroblasts (MEFs) lacking this protein have de-
fects in cell polarity, altered directional migration and in-
creased number of focal adhesions [23]. Furthermore,Cav-1 has a polarized distribution in migrating cells, being
mostly localized to the rear part of the cell where it
contributes to focal adhesion recycling and lamellipodia
inhibition [24,25]. By contrast, Y14-phosphorylated Cav-1
moves forward to the front edge of migration where it re-
cruits Csk and helps the generation of new adhesions [26].
Additional important functions of Cav-1 include endo-
cytosis, intracellular cholesterol transport and mechano-
sensing [27].
Only very few toxicological studies have related AhR
to Cav-1. In this regard, it has been shown that poly-
chlorinated biphenyls such as PCB77 induced the AhR
target gene Cyp1a1 and Cav-1 in endothelial cells, and
that such effect seems to involve an association between
AhR and Cav-1 [28,29]. These work, together with our
findings suggesting that AhR modulates Cav-1 Y14 phos-
phorylation through c-Src kinase in murine fibroblasts
[16], prompted us to investigate whether AhR modulates
Cav-1 activities in migrating mesenchymal cells.
We report here that, indeed, AhR expression modu-
lates the localization of Cav-1 at the cell membrane as
well as its distribution between microdomains and sol-
uble membrane in directionally migrating fibroblasts.
Such effects probably depend on cholesterol levels and
on the interaction between AhR and Cav-1. We propose
that Cav-1 requires the AhR-dependent control of chol-
esterol to maintain its proper membrane distribution
during cell migration.
Results
Caveolin-1 distribution in mouse fibroblasts is AhR
dependent.
We have previously found that fibroblasts lacking AhR
expression had impaired directional migration and low
levels of Cav-1 Y14 phosphorylation, likely because their
reduced c-Src activity [16]. Since Cav-1 has a relevant
role in cell polarization and in directional migration
[30], we decided to first determine by immunofluores-
cence the cellular distribution of Cav-1 under basal con-
ditions and during directional migration. For these
experiments, Cav-1 was considered to have membrane
location when present within 2 μm from the cell border
and cytosolic location when situated from 2 μm up
to the cell nucleus. While T-FGM AhR+/+ fibroblasts
had Cav-1 scattered along the cellular periphery and
the intracellular space (Figure 1A,B), T-FGM AhR−/−
fibroblasts located Cav-1 mostly to the cell periphery,
with very low intracellular levels (Figure 1A,B). Such
Cav-1 distribution was AhR dependent since it could
be mimicked by AhR knock-down (si-AhR) (Figure 2A)
in T-FGM AhR+/+ cells (Figure 1A,B), and because res-
cue of AhR expression in T-FGM AhR−/− fibroblasts
(Figure 1C) redistributed Cav-1 to a pattern resembling





Figure 1 (See legend on next page.)
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Figure 1 Cav-1 has a differential location in fibroblasts lacking AhR. (A) T-FGM AhR+/+fibroblasts transfected with a siRNA against AhR
(si-AhR) or with an scrambled sequence, and T-FGM AhR−/− fibroblasts transfected with a pcDNA-AhR or with an empty expression vector (E.V.)
were analyzed for Cav-1 expression by immunofluorescence using an Alexa 488-conjugated secondary antibody. (B) Quantification of the cellular
distribution of Cav-1 in T-FGM cells. Cav-1 was considered membranal (dashed bars) when present within a 2 μm distance from the cell border or
cytosolic (gray bars) when expressed from 2 μm up to the cell nucleus. Measurements were taken by triplicate in two cultures of each genotype.
(C) The ability of the pcDNA AhR expression construct to rescue receptor expression in AhR−/− fibroblasts was determined by immunoblotting.
(D) Primary dermal fibroblasts obtained from the skin of AhR+/+ and AhR−/− newborn mice were also analyzed as above. Regions of interest
(ROI) were selected (red line in upper panels) and the levels of fluorescence analyzed by using the “ROI profiles” tool of the Fluoview software.
The intensity per pixel was plotted for Cav-1 (green). Cav-1 was detected using a Fluoview F1000 confocal microscope. The nuclear signal is
represented in dark blue (DAPI staining). The experiments were done at least three times in independent T-FGM and dermal fibroblasts cultures.
Data are shown as mean ± s.d.
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cells since it could be also observed in primary dermal
fibroblasts from AhR−/− mice (Figure 1D). The staining
of Cav-1 was specific as shown by immunofluorescences
performed in the absence of specific antibody (Additional
file 1: Figure S1).
Cav-1 switches between detergent resistant membrane
microdomains (DRM) and the soluble membrane in mi-
grating cells [30]. We next used sucrose density gradi-
ents to investigate whether AhR could affect the
presence of Cav-1 in DRMs (Figure 2). T-FGM fibro-
blasts lacking AhR expression had a reduced amount of
Cav-1 in membrane microdomains as compared to wild
type T-FGM fibroblasts (Figure 2A, lower panels). AhR
had a causal role in the membrane distribution of Cav-1
since its knock-down in AhR+/+ T-FGM cells (Figure 2B)
reduced the amount on Cav-1 in DRM fractions (Figure 2A,
upper panels). Scramble si-AhR did not significantly re-
duce AhR levels nor had a relevant effect on Cav-1 distri-
bution (Figure 2A,B). Cav-1 is coordinately distributed
between the front and the rear in directionally migrating
cells [23,24]. At the rear forms part of caveolae whereas at
the front contributes to the synthesis of new focal adhe-
sions, probably by a process requiring its phosphorylation
at the Y14 residue [26]. We then used wound-healing
assays to analyze the location of Cav-1 in directionally
migrating AhR+/+and AhR−/− fibroblasts. Cav-1 mostly
located at the rear in T-FGM AhR−/− fibroblasts whereas
it was predominantly distributed at the front in T-FGM
AhR+/+ cells (Figure 2C). Such effect required AhR since
its down-modulation in AhR+/+ cells shifted Cav-1 to
the rear membrane whereas its re-expression in AhR−/−
fibroblasts rescued a wild-type like Cav-1 phenotype
(Figure 2C). In addition, migrating dermal fibroblasts from
AhR−/− mice also localized Cav-1 at the rear part of the
cell (Figure 2C), further supporting the implication of
AhR in the process.
AhR is present at membrane microdomains and
associates with Cav-1
The existence of a pool of AhR associated to the plasma
membrane was first suggested by the presence of theendogenous protein at the leading edge of migrating
T-FGM AhR+/+ fibroblasts and by the location of the
ectopic EYFP-AhR protein in lamellipodia of the plasma
membrane of T-FGM AhR−/− fibroblasts (Figure 3A).
Since AhR expression seemed to influence Cav-1 distri-
bution (see Figure 2), we decided to analyze if both
proteins could be part of a common complex in fibro-
blast cells. Sucrose density gradients showed that an
amount of AhR protein was found in Cav-1-containing
DRM fractions of T-FGM AhR+/+ fibroblasts (Figure 3B,
upper) and, importantly, of phenotypically unrelated
mouse Hepa1 hepatoma cells (Figure 3B, lower). The
possible association between both proteins gained add-
itional support by co-immunoprecipitation assays for
Cav-1 (Figure 3C) and AhR (Figure 3D). The results ob-
tained revealed that Cav-1 and AhR could immunopre-
cipitate each other in wild type fibroblasts, thus agreeing
with our hypothesis. Consistently, AhR and Cav-1 associ-
ation did not take place in AhR−/− fibroblasts nor it was
observed in the absence of specific antibodies (Figure
3C,D). In addition, these data are coincident with a previ-
ous study reporting that AhR co-immunoprecipitates
with Cav-1 in endothelial cells [28]. Nevertheless, to pro-
vide additional experimental strength to the association
of AhR and Cav-1, we performed confocal microscopy
co-immunofluorescence for both proteins in T-FGM
AhR+/+ fibroblasts (Figure 4A). Cav-1 had an expression
pattern with a significant protein distribution at the cell
periphery. AhR was mainly expressed in the cytosolic
and nuclear compartments although it was also readily
detectable at the cell periphery. Overlapping of both ex-
pression patterns revealed areas of the cell membrane
where AhR and Cav-1 co-localized (Figure 4A, arrow-
heads), hence confirming their potential association into a
common molecular complex. T-FGM AhR−/− fibroblasts
used as negative controls did not show any AhR expres-
sion or Cav-1 co-localization (Figure 4B). The existence of
a fraction of AhR functionally associated to the plasma
membrane was also supported by its co-localization with
the cell adhesion molecule talin (results not shown),
which, in fact, has a role in the AhR-dependent phenotype




Figure 2 Dioxin receptor expression modulates Cav-1 distribution in DRMs and at the rear of migrating fibroblasts. (A) Extracts from
T-FGM AhR+/+ cells transfected with a scramble (si-scr) or with a specific siRNA for AhR (si-AhR) and extacts from T-FGM AhR−/− cells were analyzed by
sucrose density gradient centrifugation. The presence of Cav-1 in each fraction of the gradient was analyzed by immunoblotting. Gapdh was used as a
cytoplasmic control protein. Detergent resistant membrane microdomains (DRM) correspond to the lower density (upper) fractions of the gradient. The
quantification of the percentage of Cav-1 located in DRM fractions with respect to the total amount of Cav-1 in a representative experiment is shown.
Data were normalized to the T-FGM AhR+/+ si-scr control condition. (B) RNA interference against AhR efficiently down-modulated protein expression in
T-FGM AhR+/+ fibroblasts as compared with non-specific scramble sequences (si-scr). (C) Basal AhR+/+ and AhR−/− T-FGM fibroblasts, AhR+/+ fibroblasts
transfected with a siRNA for AhR and AhR−/− cells transfected with a pcDNA-AhR expression construct were grown to confluence and analyzed for
directional migration using wound-healing assays. The same experiment was performed using dermal fibroblasts isolated from AhR+/+and
AhR−/− newborn mice (right). Cav-1 was detected by immunofluorescence in a Fluoview F1000 confocal microscope. Cell nuclei were stained
with DAPI. Arrowheads indicate rear distribution of Cav-1 in AhR−/− cells. The experiments were done at least three times in
independent T-FGM and dermal fibroblasts cultures.
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Despite the apparent co-localization of AhR and Cav-1
in membrane fractions of fibroblasts, sucrose density
gradients could not discriminate whether AhR influences
Cav-1 distribution between DRMs and the soluble mem-
brane. To address this question, we used immunofluor-
escence to analyze in directionally migrating AhR+/+ and
AhR−/− fibroblasts the co-localization of Cav-1 with
cholera toxin β as a DRM marker and with the transferrin
receptor (TfR) as a representative soluble membraneprotein (Figure 5). Cav-1 co-localized with cholera toxin
β in the front and rear areas of the plasma membrane of
T-FGM AhR+/+ cells. Notably, such co-localization was
not observed in T-FGM AhR−/− fibroblasts, which exhib-
ited their typical expression pattern of Cav-1 at the rear
part of the cell and a marked de-localization of cholera
toxin β (Figure 5A). On the contrary, Cav-1 did not co-
localize with TfR in T-FGM fibroblasts of either genotype,
showing the transferrin receptor a classical punctate pat-





Figure 3 The dioxin receptor is present in membrane microdomains and associates to Cav-1. (A) Basal AhR distribution was determined
in T-FGM AhR+/+ cells by confocal immunofluorescence using an anti-AhR antibody bound to an Alexa 488 secondary antibody (left). T-FGM
AhR−/− fibroblasts were transfected with a pEYFP-AhR expression vector and protein distribution analyzed by confocal microscopy using a
FluoView 1000 confocal microscope. Arroheads mark AhR location (right). (B) Extracts from T-FGM AhR+/+ fibroblasts and mouse hepatoma Hepa1
cells were obtained and analyzed for AhR and Cav-1 distribution by sucrose density gradients. Fractions were collected and analyzed for the
presence of AhR and Cav-1 by immunoblotting. Gapdh was used as cytoplasmic control. DRM fractions containing AhR are squared. Total lysates
(T.L.) from T-FGM AhR+/+ and AhR−/− fibroblasts were used as positive and negative controls, respectively. (C,D) T-FGM AhR+/+ and AhR−/− cells
were lysed and 1 mg of total protein immunoprecipitated with anti-Cav-1 (C) or anti-AhR (D) antibodies. Immunoprecipitates were analyzed for
the presence of AhR and Cav-1 by immunoblotting. Immunoprecipitation reactions were also done in T-FGM AhR−/− fibroblasts as negative
controls. The experiments were repeated in the absence of specific antibodies (IP:IgG) to confirm specificity. Assays were done in duplicate in
three different cell cultures.
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to DRMs in fibroblast cells.
The amount of AhR that is present in the nuclear and
cytoplasmic compartments of the cell is modulated bycell density in keratinocytes [31] and hamster fibroblasts
[5]. In those cell types, AhR is predominantly nuclear at
sparse cell densities and cytoplasmic at confluence. Since
AhR modulates Cav-1 distribution in T-FGM fibroblasts,
B
A
Figure 4 AhR and Cav-1 co-localize at the cell periphery in fibroblast cells. (A) T-FGM-AhR+/+ cells were grown on glass coverslips and
analyzed for the co-localization of AhR and Cav-1 by immunofluorescence using Fluoview F1000 confocal microscopy. Cells were incubated with
anti-Cav1 or anti-AhR primary antibodies and then with secondary antibodies coupled to Alexa 488 or Alexa 647, respectively. Signals obtained
for each individual protein have been merged on the right panel. (B) The same immunofluorescences were done in parallel in T-FGM AhR−/−
fibroblasts. Note the absence of receptor expression in AhR−/− cells. Arrowheads in panel A indicate areas of the cell membrane with apparent
AhR and Cav-1 co-localization. DAPI staining was used to label cell nuclei. The experiments were done in triplicate in two cultures of each
genotype and different areas of the cultures were analyzed.
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AhR affected the fraction of Cav-1 associated to DRMs.
T-FGM AhR+/+ fibroblasts grown at low cell density
(e.g. 30% confluence) had AhR distributed between the
nucleus and the cytosol at a 0.8:1 ratio; as cell density in-
creased to full confluence, AhR levels were significantly
reduced in the nuclear compartment (Figure 6A). Su-
crose density gradients of T-FGM AhR+/+ cell extracts
revealed that Cav-1 moved from DRM to soluble mem-
brane fractions at elevated cell densities (Figure 6B
left, 6C), an effect that was coincident with an increased
ratio in the cytosolic vs nuclear AhR. In agreement with
these results, AhR−/− fibroblasts growing at high cell
density did not significantly change Cav-1 distribution
between DRM fractions and the soluble membrane
(Figure 6B right, 6C). The effects of cell density on
Cav-1 distribution were not due to differences in Cav-1
protein levels as shown by immunoblotting analyses of
T-FGM AhR+/+ and AhR−/− cells cultured from 30% to
100% confluence (Figure 6D).Phosphorylation at Y14 modifies Cav-1 distribution but it
is AhR-independent
Phosphorylation at Y14 has been proposed to modulate
several functions of Cav-1 including caveolae internaliza-
tion and the formation of new focal adhesions [32,33].
Since T-FGM AhR−/− cells have a significant reduction
in Cav-1 Y14 phosphorylation [16], we have analyzed
whether this posttranslational modification could be in-
volved in modulating Cav-1 distribution in AhR express-
ing cells. Treatment with the protein phosphatase
inhibitor Na3VO4 significantly increased the levels of
Cav-1 Y14 phosphorylation in both T-FGM AhR+/+ and
AhR−/− fibroblasts without significantly affecting total
Cav-1 protein expression (Figure 7A). Sucrose density
gradients revealed that Na3VO4 reduced the content of
Cav-1 in DRM fractions of both T-FGM AhR+/+ and
AhR−/− fibroblasts (Figure 7B,C), indicating that an in-
crease in phosphorylation moves Cav-1 to the soluble
membrane. To try to further support this result, we transi-
ently transfected T-FGM AhR+/+ and AhR−/− cells with
B
A
Figure 5 (See legend on next page.)
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Figure 5 AhR contributes in determining Cav-1 localization to DRM domains in directionally migrating fibroblasts. (A) T-FGM
AhR+/+ and AhR−/− fibroblasts were grown to confluence on glass coverslips. Wounds were done to induce directional migration (indicated by
an arrow). The expression patterns of Cav-1 and cholera toxin β (DRM marker) were analyzed by immunofluorescence using a Fluoview F1000
confocal microscope. Cav-1 and cholera toxin β were detected using secondary antibodies conjugated with Alexa 488 and Alexa 633, respectively.
A merge of both expression profiles is shown on the right. (B) The same experiments were performed to determine the co-localization of Cav-1
with the soluble membrane marker TfR. Note that Cav-1 was detected using a secondary antibody labeled with Alexa 633 whereas TfR was bound
to an Alexa 488-labelled secondary antibody. DAPI staining was used to label cell nuclei. Arrowheads indicate co-localization of Cav-1 with cholera
toxin β in T-FGM AhR+/+ cells or Cav-1 in T-FGM AhR−/− cells. The experiment was done in triplicate in two T-FGM cultures of each genotype.
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phosphorylable mutant. Fluorescent confocal microscopy
revealed that Cav-1-GFP wild type and the Cav-1-Y14
F-GFP mutant had similar cellular distribution in either
AhR+/+or AhR−/− T-FGM fibroblasts (Figure 7D), argu-
ing that Y14 phosphorylation may not be essential in Cav-1
distribution upon AhR expression.
Cav-1 has reduced mobility in AhR-null fibroblasts
Membrane microdomains have a relevant role in caveo-
lae stabilization [34] and Cav-1 is one of the main intra-
cellular transporters of the DRM component cholesterol
[35]. Based on the previous results, we decided to
analyze if the altered distribution of Cav-1 in AhR lack-
ing cells could be reflecting defects in its mobilization
and recruitment to the plasma membrane. Fluorescence
recovery after photobleaching (FRAP) was done in
T-FGM AhR+/+ and AhR−/− fibroblasts transfected with
a Cav-1-GFP fusion protein (Figure 8A,B). Transport of
Cav-1-GFP to the cell membrane reached its maximum
value 8–10 min after bleaching in T-FGM AhR+/+ cells
whereas only a marginal recovery could be observed in
AhR−/− fibroblasts after 20 min of bleaching. However,
such impaired recovery was not due to a reduced ability of
Cav-1-loaded vesicles to migrate. Quantification by live
cell microscopy of the movement of Cav-1-GFP loaded
vesicles (Figure 8C) revealed that the accumulated and
the Euclidean distances covered by Cav-1 vesicles were
very similar in T-FGM AhR+/+ and AhR−/− fibroblasts
(Figure 8D). Therefore, AhR appears to be needed for
an efficient Cav-1 transport to the membrane although
it does not seem to affect the net distance traveled by
the vesicles.
Cholesterol is increased in the absence of AhR and it
regulates Cav-1 localization
Cholesterol is considered a regulator of Cav-1 transport
between the Golgi cisternae and the plasma membrane
[36] and a previous study has shown that AhR activation
by TCDD inhibits the expression of cholesterol biosyn-
thetic enzymes [37]. We thus investigated whether AhR
modulates basal cholesterol levels and if cholesterol is
involved in Cav-1 distribution in migrating cells. DRMs
are in a large part composed of gangliosides and cholesterol[38]. While T-FGM AhR+/+cells had a well-defined mem-
brane distribution of the GM1 ganglioside as determined
by cholera toxin β staining, T-FGM AhR−/− fibroblasts
showed a marked delocalization of GM1 (Figure 9A).
Measurement of cholesterol levels by flow cytometry using
the cholesterol-binding antibiotic filipin [39] revealed that
T-FGM AhR−/− fibroblasts had a large increase in choles-
terol content with respect to AhR+/+ cells (Figure 9B). The
same effect was also found in primary dermal fibroblasts
from AhR−/− mice, further supporting that AhR is involved
in cholesterol maintenance (Figure 9C). To determine if
cholesterol plays a role in Cav-1 distribution, T-FGM
cultures under directional migration were treated with
methyl-β-cyclodextrin (MβCD) to disrupt cholesterol-
enriched membrane microdomains or with exogenous
cholesterol. Flow cytometry confirmed that MβCD effect-
ively reduced the basal cholesterol content whereas the
addition of exogenous cholesterol increased its levels in
T-FGM AhR+/+ and AhR−/− fibroblasts (Figure 9D,E).
The results showed that T-FGM AhR+/+ fibroblasts treated
with exogenous cholesterol re-localized Cav-1 to the rear
part of the cell whereas AhR−/− fibroblasts treated with
MβCD de-localized Cav-1 from the rear to the front
edge of the cell (Figure 9F). Thus, an increase in choles-
terol could switch the pattern of Cav-1 distribution of
AhR+/+ cells to the AhR-null-like phenotype. Conversely,
disruption of membrane microdomains by MβCD induced
a wild type-like distribution of Cav-1 in AhR−/− cells. Su-
crose density gradients could not be performed under these
experimental conditions since MβCD provoked a drastic
reduction in the amount of Cav-1 in DRM fractions, per-
haps because of an almost complete depletion of choles-
terol, as reported [40].
Caveolae endocytosis is enhanced in fibroblasts lacking
AhR
The fact that AhR deficiency alters Cav-1 distribution at
DRMs, and since caveolae disruptors such as MβCD are
cholesterol sequesters [41], lead us to investigate the ex-
istence of alterations in endocytosis, a process in which
Cav-1 has a relevant role [34,42]. We used the classical
caveolae-dependent cargo protein BSA-FITC [43,44]
to perform endocytosis assays in T-FGM AhR+/+




Figure 6 Cell density modulates Cav-1 distribution in an AhR-dependent manner. (A) T-FGM AhR+/+cells were cultured at different cell
densities from low (30%) to high (100%) confluence and the presence of the AhR protein analyzed by immunoblotting in nuclear “N” and
cytosolic “C” extracts. The catalytic subunit of the RNA polymerase III and Gapdh were used as markers for the nuclear and cytosolic compartments,
respectively. The ratio of nuclear:cytosolic AhR is indicated below the blot. (B) T-FGM AhR+/+ and AhR−/− fibroblasts cultured at different
confluences were used to obtain protein extracts that were analyzed for Cav-1 and AhR distribution using sucrose density gradients. Gapdh
was used as a marker for the soluble fractions. The presence of each protein was determined by immunoblotting using specific antibodies.
(C) The content of Cav-1 in DRMs and soluble fractions of T-FGM AhR+/+ and AhR−/− fibroblasts was quantified and plotted for each cell dens-
ity. At least 4 cultures were used for each experimental condition and cell genotype. A representative experiment and its quantification are
shown. (D) Total cell extracts obtained from T-FGM AhR+/+ and AhR−/− fibroblasts grown at 30% to 100% confluence were analyzed for AhR
expression by immunoblotting. β-tubulin was used to confirm equal loading and protein integrity. Determinations were done in duplicate in
two cultures of each genotype.
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respect to AhR+/+ cells (Figure 10A,B). Notably, AhR
knock-down in T-FGM AhR+/+ cells increased BSA-
FITC endocytosis to a comparable extent to that found
in AhR−/− cells (Figure 10A,B). A similar effect could be
also observed in primary dermal fibroblasts from AhR-
null mice (Figure 10C,D), indicating that AhR has a rolein caveolae-driven endocytosis. The addition of the
caveolae specific disruptors MβCD and nystatin signifi-
cantly reduced BSA-FITC endocytosis in cells of both
genotypes, thus confirming the implication of Cav-1
in the process (Figure 10E). Consistently, addition of
exogenous cholesterol, a specific inducer of caveolae-




Figure 7 Y14 phosphorylation does not have a definitive role in Cav-1 distribution upon AhR expression. (A) T-FGM AhR+/+ and AhR−/−
fibroblasts were treated for 1 h with the phosphatase inhibitor Na3VO4 or with solvent. Total protein extracts were analyzed by immunoblotting
with specific antibodies against total and phosphorylated Cav-1-Y14 protein. (B) T-FGM cells of both genotypes were treated with Na3VO4 or with
solvent and cellular extracts analyzed for Cav-1 distribution by sucrose density gradients. Immunoblotting was used to detect Cav-1 and the
cytosolic marker Gapdh. (C) Cav-1 was quantified in DRMs and in soluble membrane fractions and the results represented with respect to the
total amount of Cav-1 in the gradient. A representative experiment is shown. (D) T-FGM AhR+/+ and AhR−/− fibroblasts were grown on glass
coverslips and transfected with a wild type Cav-1-GFP or a Cav-1-Y14F-GFP non-phosphorylable mutant. Cav-1 distribution was analyzed by live
cell microscopy using a CellR fluorescence equipment. The experiments were done in duplicate in two cultures of each cell genotype.
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again supporting a role for cholesterol in caveolae endo-
cytosis and in the distribution of Cav-1 in membrane
microdomains.
Discussion
Among the recently discovered physiological functions
of AhR [3], its contribution to the control of cell adhe-
sion and migration is attracting considerable interest.
We have shown that AhR has novel functions in mesen-
chymal fibroblasts cells by controlling the number and
size of focal adhesions and the stability of actin stress fi-
bers [3,10,15]. More recently, we have described a mech-
anism integrating AhR in cell adhesion and migration
through the regulation of the Cbp-Csk-Src pathway ul-
timately leading to β1 integrin activation [16]. Interest-
ingly, the functional interaction between AhR and
Src-dependent signaling has been also suggested by other
authors as AhR activation by TCDD increases c-Src activ-
ity in human MCF-10A and HepG2 cells [12,46]. Notably,
these studies open the possibility to the existence ofmembrane-related functions of AhR that could be inde-
pendent from its activity as a transcription factor.
A major finding of this work is the identification of a
fraction of AhR associated with plasma membrane mi-
crodomains and in apparent co-localization with Cav-1,
a protein involved in cell migration and a relevant com-
ponent of the c-Src and β1-integrin signaling pathways
[23,30]. Interestingly, a recent work has shown that ex-
ogenous coplanar polychlorinated biphenyls induced the
co-immunoprecipitation of AhR and Cav-1 in endothe-
lial cells [28], suggesting that the association between
both proteins could be a general regulatory mechanism
defining a novel signal transduction pathway.
AhR deficiency altered Cav-1 distribution in the cell
not only by inducing its accumulation at the cell periph-
ery but also by shifting its localization between the front
and the rear edges of the plasma membrane. Cav-1 has
relevant roles in cell polarization and in directional mi-
gration and they are in part due to its differential
localization in the cell [25,30,47]. During cell migration,




Figure 8 AhR is required to recruit Cav-1-containing vesicles to the membrane. (A) T-FGM AhR+/+ and AhR−/− fibroblasts were transfected
with a Cav-1-GFP fusion protein and its recruitment to the membrane analyzed by fluorescence recovery after photobleaching (FRAP) using live
cell microscopy. Images were taken before (pre-bleach) and up to 20 min after bleaching. The bleached area is indicated with a red square on
the left panels. The intensities of Cav-1-GFP signals were analyzed in selected areas (green rectangles) and the profiles obtained are shown in the
lower panels. Vertical arrows mark fluorescence recovery. (B) Fluorescence recovery for cells of each genotype was quantified with respect to zero
time. (C) T-FGM AhR+/+ and AhR−/− cells were transfected with a Cav-1-GFP expression vector and the distance covered by the vesicles analyzed
by live cell microscopy under controlled conditions. Vesicle movement was determined by taking one image on the Z axis for each millimeter
during 20 min. Representative images correspond to the projection along the Z axis of pictures taken at one fixed time. (D) The accumulated
and the Euclidean distances covered by Cav-1-GFP vesicles were measured and plotted for T-FGM AhR+/+ and AhR−/− cells. At least 15 vesicles
from at least 3 different cells were analyzed. The assays were done in triplicate cultures of each cell line.
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cell contractility. The Cav-1 that accumulates at the
leading edge of migrating cells contributes to the forma-
tion of new focal adhesions and appears to be phosphor-
ylated and unrelated to caveolae [26]. Notably, AhR
deficient fibroblasts under directional migration accu-
mulated most of their Cav-1 at the rear membrane in
detriment of the leading edge, an effect that could help
explain their increased adhesion and lower migration
rates [15,16]. The functional association between AhR
and Cav-1 in the control of cell migration gains add-
itional support by the following observations: (i) AhR is
present at the plasma membrane of migrating cells and afraction of this protein co-localizes with Cav-1; (ii) in
presence of AhR, Cav-1 is preferentially distributed to
plasma membrane DRMs; (iii) AhR and Cav-1 co-
immunoprecipitate into a presumable common protein
complex; (iv) increasing the cytosolic vs nuclear ratio
of AhR enriches Cav-1 content in DRMs, and (v) AhR
knock-out produces the opposite phenotypes in fibroblast
cells. It is therefore likely that a pool of membrane-related
AhR interacts with Cav-1 to regulate cell adhesion and
migration.
Previous studies reported that cell density modulates
the intracellular localization of AhR in keratinocytes [31]





Figure 9 AhR modulates basal cholesterol levels in fibroblasts. (A) T-FGM AhR+/+ and AhR−/− cultures were stained with the cholesterol dye
M1 ganglioside (GM1) and membrane microdomains analyzed by fluorescence confocal microscopy. (B,C) T-FGM cells (B) and primary dermal
fibroblasts (C) of both genotypes were grown on glass coverslips, fixed and stained with the cholesterol-binding antibiotic filipin III in order to
detect endogenous free cholesterol. Stained cells were analyzed by flow cytometry and the fluorescence intensity profiles represented.
(D,E) T-FGM AhR+/+ and AhR−/− cells were incubated for 16 h with 10 mM MβCD, 100 mM cholesterol plus 2.5 mM MβCD (cholesterol) or
solvent and analyzed for cholesterol content by flow cytometry as indicated above. Fluorescence profiles were compared graphically. (F) T-FGM cells
of both genotypes were grown to confluence and treated with MβCD or cholesterol as indicated above. Wound healing was used to induce
directional migration. Cav-1 distribution was analyzed by fluorescence confocal microscopy in a Fluoview F1000 equipment. DAPI staining
was used to label cell nuclei. Arrowheads mark Cav-1 location. The experiments were done in duplicate in two cultures of each genotype.





Figure 10 Lack of AhR increases caveolae-dependent endocytosis. (A) Basal T-FGM AhR+/+ and AhR−/− fibroblasts and T-FGM AhR+/+ cells
transfected with a si-AhR were grown on glass coverslips for 24 h. Cells were then incubated with serum-free medium for 2 h and with BSA-FITC
for 1, 2 or 4 h. Cultures were observed in a Fluoview F1000 fluorescent confocal microscope. Cell nuclei were stained with Hoechst 33342.
(B) Total fluorescence per cell was digitally calculated with the ImageJ software and represented for each treatment. (C) The same assay was
performed in dermal fibroblasts from AhR+/+ and AhR−/− newborn mice measuring endocytosis after 4 h of treatment. (D) Total fluorescence
per cell was digitally calculated with the ImageJ software. (E) T-FGM cells of both genotypes were treated with 10 mM MβCD, 15 mg/ml nystatin
or solvent (control) for 1 h prior to the incubation with BSA-FITC for 4 h. Endocytosis was quantified and analyzed as indicated above. (F) T-FGM
AhR+/+ and AhR−/− cells were pre-treated with 100 mM cholesterol plus 2.5 mM MβCD (choles) or solvent (control) for 16 h prior to the
incubation with BSA-FITC for 4 h. Endocytosis was quantified and analyzed as indicated above. Data are shown as mean ± s.d. from experiments
performed in duplicate in three independent cultures.
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induced its accumulation in the cytoplasm. Based on
these studies, we hypothesized that modifying the intra-
cellular localization of AhR through changes in cell
density should affect the membrane distribution of
Cav-1. In agreement, as cell density increased, AhR waspredominantly cytosolic and Cav-1 shifted its distribu-
tion from DRMs to the soluble membrane. It could be
considered that the reduced migration observed in con-
fluent fibroblasts may involve Cav-1 mobilization to the
soluble membrane in parallel to the accumulation of
cytosolic AhR. The plausible influence of cytosolic AhR
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additional support from the fact that AhR−/− fibroblasts
did not exhibit changes in Cav-1 distribution upon in-
creasing cell density.
Phosphorylation at Y14 has been associated to Cav-1
localization and internalization in response to diverse
stimuli including shear stress [33] and partial hepatec-
tomy [32]. An increase in Y14 phosphorylation of Cav-1
reduced its DRM levels in both AhR-expressing and
AhR-lacking fibroblasts, initially suggesting that phos-
phorylation is relevant to the mechanism. However, a
non-phosphorylable Y14F Cav-1 mutant had a membrane
distribution similar to that of the wild type protein, sug-
gesting that phosphorylation may not be essential to the
process. In addition, the fact that, despite their lower basal
levels of Y14 Cav-1 phosphorylation, AhR−/− fibroblasts
efficiently reduced their Cav-1 content in DRMs upon
Na3VO4 treatment suggest the existence of an still not
clarified intricate mechanism regulating that process.
Given that the role of phosphorylation on Cav-1 function
is in many aspects only partially known, further work is
needed to elucidate the phenotype of AhR-null cells and
to what extent Y14 phosphorylation is relevant in modulat-
ing Cav-1 localization in fibroblasts.
Recruitment to DRMs is essential for Cav-1 to control
cell migration [34]. Real time FRAP experiments showed
that AhR−/− cells were less capable of mobilizing Cav-1
containing vesicles to the plasma membrane. Such defi-
cient recruitment of Cav-1 could be due to impaired
cytoskeleton-dependent transport and/or to altered endo-
cytosis. However, impairment in cytoskeleton-associated
transport could be excluded because the potential of Cav-
1 vesicles to travel inside the cell was not affected by AhR
expression. Endocytosis is a process functionally linked to
membrane microdomains and, in this regard, not only
Cav-1 is needed for the endocytic recycling of membrane
proteins [47], but also the membrane microdomains are
required for caveolae-dependent endocytosis [18]. T-FGM
and primary dermal fibroblasts lacking AhR showed in-
creased endocytosis of the Cav-1 cargo protein BSA-FITC
that was partially blocked by caveolae disruptors and po-
tential cholesterol sequesters MβCD and nystatin [48].
Cav-1 functions are tightly related to cholesterol as Cav-1
is the main carrier of that lipid [42] and because choles-
terol stabilizes Cav-1-rich caveolae [19]. Consistent with a
role of AhR in regulating Cav-1 through cholesterol, we
have found that AhR−/− fibroblasts had increased levels of
endogenous cholesterol and an enhanced endocytic re-
sponse to exogenous cholesterol that could account for
their more efficient caveolae-dependent endocytosis.
Therefore, cholesterol could be an intermediate molecule
in the signaling from AhR to Cav-1. This hypothesis
agrees with a previous study showing that AhR activation
by TCDD inhibits cholesterol biosynthesis in hepatic cells[37]. Nevetheless, more work needs to be performed to
fully understand the reduced presence of Cav-1 in DRM
fractions of AhR−/− cells given that cholesterol is a major
component of DRMs and that these cells have increased
caveolae-dependent endocytosis. From a functional point
of view, cholesterol was also involved in AhR-dependent
Cav-1 distribution during directional migration since dis-
ruption of membrane microdomains rescued AhR−/− cells
to a wild-type-like phenotype whereas exogenous choles-
terol did the opposite and induced an AhR-null-like Cav-1
phenotype in AhR+/+ fibroblasts. Our data are consistent
with previous studies showing that a high cholesterol con-
tent reduces the mobility of membrane proteins [49] and
disorganizes membrane microdomains [50].
In summary, we report here that the dioxin receptor is
a novel regulator of caveolin-1 distribution and function
in migrating mouse fibroblasts (Figure 11). Such effects
likely involve a subpopulation of DRM-related AhR with
the potential to associate to Cav-1. Cholesterol appears
an effector of the Cav-1 phenotype probably by regulat-
ing caveolae-dependent endocytosis during directional
migration. Thus, AhR and Cav-1 could be acting in con-
cert to modulate cell migration during normal and
pathological situations.
Conclusions
This study reveals that AhR has a role in controlling the
membrane distribution of Cav-1 during fibroblast cell mi-
gration (Figure 11). Importantly, such effect seems to take
place by a mechanism involving cholesterol-enriched
membrane microdomains. The functional interaction be-
tween AhR and Cav-1 likely has an important contribu-
tion to the motility of mesenchymal cells, and emphasizes
the relevance of both proteins in the migration of tumor
cells. Moreover, AhR and Cav-1 could have a coordinated
mechanism of co-localization to adjust the rates of migra-
tion to different cellular conditions, under both physio-
logical and pathological situations.
Materials and methods
Cell culture
Immortalized wild type (AhR+/+) and AhR-null (AhR−/−)
T-FGM mouse fibroblasts were produced as described
[10] using primary cells from AhR+/+ and AhR−/− mice
[51]. They were grown in DMEM/F12 medium containing
10% FBS, 2 mM L-glutamine, 50 μg/ml gentamycin and
11 mM D-glucose at 37°C in a 5% CO2 atmosphere. Der-
mal fibroblasts were obtained from the skin of 2-days-old
AhR+/+ and AhR−/− newborn mice following established
protocols [52,53]. Briefly, the skins were floated on con-
centrated trypsin and the dermal layers were isolated from
the epidermises. Dermises were then minced and trypsi-
nized and the resulting cell suspension was quickly centri-
fuged. The cellular supernatant was removed and cultured
Figure 11 Schematic representation of the signaling pathway proposed for the AhR-dependent control of cell migration. The regulation
of c-Src and β1-integrin through the AhR target gene Cbp/Pag1 has been reported in our previous study [16]. Here we propose that a certain
amount of cytosolic AhR locates in the vicinity of the plasma membrane during cell migration. This membrane-related AhR associates into a
common protein complex with Cav1 and favors its enrichment in DRMs of the plasma membrane. It is likely that this functional relationship
between AhR and Cav-1 helps establish a suitable Cav-1 distribution at the leading edge of directionally migrating fibroblasts. Cholesterol
probably has a relevant role in this mechanism because it is a major lipid in defining DRM regions in the plasma membrane and because its
levels are controlled by AhR. The importance of phosphorylation in determining the localization of Cav-1 is not yet clearly defined despite
being a target of c-Src kinase in T-FGM fibroblasts [16].
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by the Bioethics and Biosecurity Commission of the
University of Extremadura. Mice had free access to
water and rodent chow.Antibodies and reagents
Anti-AhR antibodies were from Biomol (Plymouth, PA,
USA) or Santa Cruz Biotechnology (immunofluorescence,
Santa Cruz, CA, USA); anti-β-actin was from Sigma-
Aldrich (St. Louis, MO, USA) and anti-Cav-1, anti-Y14
p-Cav-1 and anti-Gapdh were from Becton-Dickinson
(Franklin Lakes, NJ, USA). Protein A/G plus Sepharose
was from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Small interfering RNAs (siRNA) and scramble se-
quences for AhR were from Dharmacon (Lafayette, CO,
USA). Cholera toxin-β to stain ganglioside GM1 was from
Sigma and the anti-transferrin receptor (TfR) antibody
was from Novus Biologicals (Littletown, CO, USA). ThepcDNA-AhR expression vector was produced and charac-
terized essentially as indicated [52].Co-immunoprecipitation and immunoblotting
Protein immunoprecipitation using T-FGM AhR+/+ and
AhR−/− cultures was performed essentially as described
[54,55]. In brief, cells were lysed in a solution containing
50 mM Tris HCl pH 7.4, 125 mM NaCl, 2 mM DTT,
50 μM EGTA, 1 mM phenyl-methyl sulfonyl fluoride,
1% Nonidet P-40 and 4 μg/ml Complete protease inhibi-
tor cocktail (Roche). Aliquots of 1 mg protein were incu-
bated with 2 μg of anti-AhR antibody and protein-A/G
plus Sepharose beads overnight at 4°C. Beads were then
washed twice with buffer A (20 mM Tris–HCl pH 7.4,
50 mM NaCl, 1% Nonidet P-40, 10 mM EDTA, 1 mM
sodium orthovanadate, 50 mM NaF, 0.5 mM PMSF and
4 μg/ml Complete protease inhibitor cocktail) and buffer
B (25 mM Tris–HCl pH 7.5, 150 mM NaCl and 1 mM
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immunoblotting as described [55].
Transient transfection and RNA interference
T-FGM cells were transiently transfected by nucleofec-
tion using a MicroPorator MP-100 (Digital-Bio) as previ-
ously indicated [56]. The AhR-EYFP (enhanced yellow
fluorescent protein) expression vector was produced
by cloning the full-length murine AhR cDNA into the
pEYFP vector as indicated [53]. The pEGFP (enhanced
green fluorescent protein)-Cav-1 and the non-phosphorylable
pEGFP-Cav-1-Y14F expression constructs were generously
provided by Dr. Lisardo Boscá (Instituto de Investigaciones
Biomédicas, Madrid, Spain). Expression vectors AhR-EYFP,
pEGFP-Cav-1 and pEGFP-Cav-1-Y14F were used at 3 μg/ml
per 106 cells and experiments were performed 24–48 h
after transfection. RNA interference for AhR was per-
formed by transient transfection of specific small interfering
RNAs (siRNA) or scrambled sequences (scr-RNA) at con-
centrations ranging from 20 nM to 100 nM.
Discontinuous sucrose density gradients
To analyze protein distribution at detergent-resistant mem-
brane microdomains (DRM), T-FGM AhR+/+and AhR−/−
cells were collected in PBS, centrifuged and solubilized for
30 min a 4°C with gentle rotation in TNET buffer contain-
ing 50 mM Tris–HCl pH 7.5, 150 mM NaCl, 5 mM EDTA,
0.25% Triton X-100, 1 mM PMSF and 4 μg/ml Complete
protease inhibitor cocktail (Roche). Cell lysates were then
mixed with a 90% sucrose solution and deposited at the
bottom of an ultracentrifuge tube. Samples were consecu-
tively layered with 3.5 volumes of 35% sucrose and with 1
volume of 16% sucrose (dissolved in TNET buffer). Centri-
fugation was performed at 180.000 g for 16 h at 4°C in a
Beckman-Coulter L-90K ultracentrifuge. Following centri-
fugation, aliquots of 200 μl were collected in such a way
that DRM-enriched fractions corresponded to those lo-
cated at the top of the gradient.
Immunofluorescence and live cell microscopy
T-FGM and primary dermal fibroblasts cultures were fixed
for 20 min at room temperature in 4% paraformaldehyde
(Polysciences Inc) or for 10 s in ice-cold methanol. For
immunofluorescence, cultures were incubated with pri-
mary antibodies for AhR or Cav-1 and then with the ap-
propriate secondary antibody labeled with Alexas 488, 633
or 647. Cells were washed and analyzed in a Fluoview
1000 confocal microscope (Olympus). The cellular distri-
bution of AhR-EYFP and EGFP-Cav-1 labelled proteins
was also analyzed in a Fluoview 1000 confocal microscope
(Olympus). To analyze Cav-1 during directional cell migra-
tion, wounds were performed with a pipette tip in con-
fluent T-FGM cultures and cells were fixed, processed
and observed 8–16 h later. For live cell microscopy,T-FGM fibroblasts growing on glass coverslips were trans-
fected with EGFP-Cav-1 or incubated with CTB-alexa633
for DRM staining. Next, Hoechst 33342 was added to label
cell nuclei and cultures were followed under controlled
temperature and humidity in an Olympus CellR fluores-
cence microscope. In some experiments, DAPI was used
to stain cell nuclei. Fluorescence distribution analysis was
performed using the FV1000 software (Olympus). Objec-
tives used were 60x oil immersion (NA 1.35) and 40x (NA
1.05). Excitation wavelengths were: 405 nm (DAPI),
488 nm (Alexa 488 and EYFP), 647 (Alexa 647) and 633
(Alexa 633). Cells stained only with secondary antibody
were used as negative controls.
Free cholesterol measurements
T-FGM and primary dermal fibroblasts were fixed with
2% paraformaldehyde for 10 min, washed with PBS and
incubated for 30 min at room temperature with 5 μg/ml
of the cholesterol-binding filipin III (Sigma). After propi-
dium iodine staining to eliminate cellular debris, cul-
tures were analyzed by flow cytometry in a Mo-Flo XDP
(Beckman-Coulter) equipped with a 355 nm UV laser to
excite filipin III and a 488 nm solid-state laser to excite
propidium iodide (PI). A number of 104 cells were ana-
lyzed per experimental condition.
Modulation of basal cholesterol levels
The effects of cholesterol in endocytosis were analyzed by
depleting or increasing its basal concentration. Basal chol-
esterol levels were reduced by treating T-FGM fibroblasts
with 10 mM MβCD for 1 h or with 50 mg/ml nystatin for
15 min. To enrich basal cholesterol, T-FGM cells were in-
cubated with a solution of 2.5 mM MβCD plus 100 mM
cholesterol for 16 h as described [57]. For long-term
treatments, MβCD was used at 2.5 mM for 16 h.
Measurements of intracellular vesicle mobility
T-FGM fibroblasts seeded in 13 mm glass coverslips were
transfected with pEGFP-Cav-1 and observed 24 h later by
living cell microscopy under controlled temperature and
humidity. Images were obtained in a 1 mm section along
the Z-axis every minute for a total of 15 min. A Z-axis
composition for the time-dependent vesicle progression
was made and their movement in up to 20 cells was
followed by using the “Tracking” tool of the ImageJ soft-
ware. Accumulated and Euclidean distances covered by
each vesicle were calculated and compared essentially as
described [16]. Results from the vesicles tracked from 3
different representative cells are shown.
Fluorescence recovery after photobleaching (FRAP)
measurements
T-FGM cells were transfected with pEGFP-Cav-1 and ob-
served by confocal microscopy 24 h after transfection.
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in a 10 μm-side region was bleached using 30 pulses of a
488 nm laser at 50% power (<50 mW). Images were taken
before bleaching and every minute thereafter for a total of
15–20 min. Data were analyzed using the “Plot profiles”
tool of the Image J software and FV10 software (Olympus).
Endocytosis assays
Endocytosis measurements were done basically as de-
scribed [58]. Briefly, T-FGM fibroblasts growing in
complete medium were changed to serum-free medium
for 2 h. During this time, cells were treated with MβCD,
nystatin or cholesterol. After washing and addition of
fresh serum-free medium, 1 μM BSA-FITC (Sigma) was
added for 30 min or 24 h. Cell nuclei were stained with
Hoechst 33342 for the last 20 minutes of incubation and
cultures were washed and analyzed by confocal micros-
copy. Total fluorescence per cell was quantified in 3 dif-
ferent fields for each experimental condition.
Statistical analyses
Data are shown as mean ± SD. Comparison between ex-
perimental conditions was done using GraphPad Prism
6.0 software (GraphPad). The student’s t test was used to
analyze differences between two experimental groups or
ANOVA for the analyses of three or more groups. Ex-
periments were done in duplicate or triplicate in two or
three biological replicates of each cell line.
Additional file
Additional file 1: Figure S1. Negative control for Cav-1 immunofluorescence.
T-FGM AhR+/+ fibroblasts were grown, fixed and processed for
immunoflourescence using the same conditions as in Figure 1 except
that the anti-Cav-1 antibody was not included. Secondary antibody
used was Alexa 488. Cell nuclei were stained with DAPI. Transmitted
light images were also taken from the same cultures. Bar corresponds
to 50 μm.
Abbreviations
AhR: Dioxin receptor; Cav-1: Caveolin-1, DRM, detergent resistant
microdomains; FRAP: Fluorescence recovery after photobleaching;
GFP: Green fluorescent protein; MbCD: Methyl-β-cyclodextin; TfR: Transferrin
receptor; YFP: Yellow fluorescent protein; si-RNA: Small interfering RNA.
Competing interests
The authors declare that they have no competing interests
Authors’ contributions
JRB participated in all the experiments reported and in conceiving the study;
AAB contributed to the fluorescent confocal microscopy and FRAP
experiments; ERL and MCT helped with the experiments involving dermal
fibroblasts and density gradients; JMCG participated in the experiments
related to EYFP detection; AE and MAP participated in the analyses of
p-Cav-1. PMFS participated in the design and coordination of the study and
wrote the manuscript. All authors read and approved the final manuscript.
Acknowledgments
This work was supported by grants to P.M.F-S. from the Spanish Ministry of
Science and Innovation (SAF2008-00462 and BFU2011-22678) and from theJunta de Extremadura (GR10008). Research at P.M.F-S laboratory is also
funded by the Red Temática de Investigación Cooperativa en Cáncer (RTICC),
Fondo de Investigaciones Sanitarias (FIS), Carlos III Institute, Spanish Ministry
of Health (RD12/0036/0032). J.R.B. was a F.P.U. program fellow from the
Spanish Ministry of Education and Sciences. All Spanish funding is co-
sponsored by the European Union FEDER program. The support and help of
the Servicio de Técnicas Aplicadas a las Biociencia (STAB) of the Universidad
de Extremadura is greatly acknowledged. We are very grateful to Dr. Lisardo
Boscá (Instituto de Investigaciones Biomédicas, Madrid, Spain) for providing
the Cav-1-GFP and the Cav-1Y14F-GFP expression vectors and to Dr. Miguel
A. Alonso Lebrero (Centro de Biología Molecular Severo Ochoa, Madrid,
Spain) for assistance with the sucrose density gradient method. The technical
support of Eva Barrasa is greatly appreciated.
Author details
1Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias,
Universidad de Extremadura, 06071 Badajoz, Spain. 2Servicio de Técnicas
Aplicadas a las Biociencias, Universidad de Extremadura, 06071 Badajoz,
Spain. 3Department of Developmental and Regenerative Biology, Mount
Sinai School of Medicine, 10029 New York, USA. 4Departamento de Biología
Vascular e Inflamación, Centro Nacional de Investigaciones Cardiovasculares
(CNIC), 28029 Madrid, Spain.
Received: 5 April 2014 Accepted: 5 September 2014
References
1. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ: Role of aryl hydrocarbon
receptor-mediated induction of the CYP1 enzymes in environmental
toxicity and cancer. J Biol Chem 2004, 279:23847–23850.
2. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J,
Fujii-Kuriyama Y, Ishikawa T: Benzo[a]pyrene carcinogenicity is lost in
mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 2000,
97:779–782.
3. Pohjanvirta R: The AH receptor in Biology and Toxicology. New York: John
Wiley & Sons; 2012.
4. Sauzeau V, Carvajal-Gonzalez JM, Riolobos AS, Sevilla MA, Menacho-Marquez
M, Roman AC, Abad A, Montero MJ, Fernandez-Salguero P, Bustelo XR:
Transcriptional factor aryl hydrocarbon receptor (Ahr) controls
cardiovascular and respiratory functions by regulating the expression
of the Vav3 proto-oncogene. J Biol Chem 2011, 286:2896–2909.
5. Cho YC, Zheng W, Jefcoate CR: Disruption of cell-cell contact maximally
but transiently activates AhR-mediated transcription in 10T1/2 fibroblasts.
Toxicol Appl Pharmacol 2004, 199:220–238.
6. Sadek CM, Allen-Hoffmann BL: Cytochrome P450IA1 is rapidly induced in
normal human keratinocytes in the absence of xenobiotics. J Biol Chem
1994, 269:16067–16074.
7. Qin H, Powell-Coffman JA: The Caenorhabditis elegans aryl hydrocarbon
receptor, AHR-1, regulates neuronal development. Dev Biol 2004, 270:64–75.
8. Barouki R, Coumoul X, Fernandez-Salguero PM: The aryl hydrocarbon
receptor, more than a xenobiotic-interacting protein. FEBS Lett 2007,
581:3608–3615.
9. Gomez-Duran A, Carvajal-Gonzalez JM, Mulero-Navarro S, Santiago-Josefat B,
Puga A, Fernandez-Salguero PM: Fitting a xenobiotic receptor into cell
homeostasis: how the dioxin receptor interacts with TGFbeta signaling.
Biochem Pharmacol 2009, 77:700–712.
10. Mulero-Navarro S, Pozo-Guisado E, Perez-Mancera PA, Alvarez-Barrientos A,
Catalina-Fernandez I, Hernandez-Nieto E, Saenz-Santamaria J, Martinez N, Rojas
JM, Sanchez-Garcia I, Fernandez-Salguero PM: Immortalized mouse mammary
fibroblasts lacking dioxin receptor have impaired tumorigenicity in a
subcutaneous mouse xenograft model. J Biol Chem 2005, 280:28731–28741.
11. Roman AC, Carvajal-Gonzalez JM, Rico-Leo EM, Fernandez-Salguero PM:
Dioxin receptor deficiency impairs angiogenesis by a mechanism
involving VEGF-A depletion in the endothelium and transforming
growth factor-beta overexpression in the stroma. J Biol Chem 2009,
284:25135–25148.
12. Tomkiewicz C, Herry L, Bui LC, Metayer C, Bourdeloux M, Barouki R, Coumoul X:
The aryl hydrocarbon receptor regulates focal adhesion sites through a
non-genomic FAK/Src pathway. Oncogene 2013, 32:1811–1820.
13. Diry M, Tomkiewicz C, Koehle C, Coumoul X, Bock KW, Barouki R, Transy C:
Activation of the dioxin/aryl hydrocarbon receptor (AhR) modulates cell
Rey-Barroso et al. Cell Communication and Signaling 2014, 12:57 Page 19 of 19
http://www.biosignaling.com/content/12/1/57plasticity through a JNK-dependent mechanism. Oncogene 2006,
25:5570–5574.
14. Carvajal-Gonzalez JM, Roman AC, Cerezo-Guisado MI, Rico-Leo EM,
Martin-Partido G, Fernandez-Salguero PM: Loss of dioxin-receptor
expression accelerates wound healing in vivo by a mechanism
involving TGF{beta}. J Cell Sci 2009, 122:1823–1833.
15. Carvajal-Gonzalez JM, Mulero-Navarro S, Roman AC, Sauzeau V, Merino JM,
Bustelo XR, Fernandez-Salguero PM: The dioxin receptor regulates the
constitutive expression of the vav3 proto-oncogene and modulates cell
shape and adhesion. Mol Biol Cell 2009, 20:1715–1727.
16. Rey-Barroso J, Colo GP, Alvarez-Barrientos A, Redondo-Munoz J, Carvajal-Gonzalez
JM, Mulero-Navarro S, Garcia-Pardo A, Teixido J, Fernandez-Salguero PM:
The dioxin receptor controls beta1 integrin activation in fibroblasts
through a Cbp-Csk-Src pathway. Cell Signal 2013, 25:848–859.
17. Fra AM, Williamson E, Simons K, Parton RG: De novo formation of caveolae
in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci U S A
1995, 92:8655–8659.
18. Parton RG, Hanzal-Bayer M, Hancock JF: Biogenesis of caveolae: a structural
model for caveolin-induced domain formation. J Cell Sci 2006, 119:787–796.
19. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG:
Caveolin, a protein component of caveolae membrane coats. Cell 1992,
68:673–682.
20. Le Lay S, Kurzchalia TV: Getting rid of caveolins: phenotypes of caveolin-deficient
animals. Biochim Biophys Acta 2005, 1746:322–333.
21. Patani N, Martin LA, Reis-Filho JS, Dowsett M: The role of caveolin-1 in
human breast cancer. Breast Cancer Res Treat 2012, 131:1–15.
22. Tanase CP: Caveolin-1: a marker for pancreatic cancer diagnosis. Expert Rev
Mol Diagn 2008, 8:395–404.
23. Grande-Garcia A, Echarri A, de Rooij J, Alderson NB, Waterman-Storer CM,
Valdivielso JM, del Pozo MA: Caveolin-1 regulates cell polarization and
directional migration through Src kinase and Rho GTPases. J Cell Biol
2007, 177:683–694.
24. Hill MM, Daud NH, Aung CS, Loo D, Martin S, Murphy S, Black DM, Barry R,
Simpson F, Liu L, Pilch PF, Hancock JF, Parat MO, Parton RG: Co-regulation
of cell polarization and migration by caveolar proteins PTRF/Cavin-1 and
caveolin-1. PLoS One 2012, 7:e43041.
25. Parat MO, Anand-Apte B, Fox PL: Differential caveolin-1 polarization in
endothelial cells during migration in two and three dimensions. Mol Biol
Cell 2003, 14:3156–3168.
26. Beardsley A, Fang K, Mertz H, Castranova V, Friend S, Liu J: Loss of caveolin-1
polarity impedes endothelial cell polarization and directional movement.
J Biol Chem 2005, 280:3541–3547.
27. van Deurs B, Roepstorff K, Hommelgaard AM, Sandvig K: Caveolae:
anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol
2003, 13:92–100.
28. Lim EJ, Majkova Z, Xu S, Bachas L, Arzuaga X, Smart E, Tseng MT, Toborek M,
Hennig B: Coplanar polychlorinated biphenyl-induced CYP1A1 is regulated
through caveolae signaling in vascular endothelial cells. Chem Biol Interact
2008, 176:71–78.
29. Majkova Z, Smart E, Toborek M, Hennig B: Up-regulation of endothelial
monocyte chemoattractant protein-1 by coplanar PCB77 is caveolin-
1-dependent. Toxicol Appl Pharmacol 2009, 237:1–7.
30. Grande-Garcia A, del Pozo MA: Caveolin-1 in cell polarization and
directional migration. Eur J Cell Biol 2008, 87:641–647.
31. Ikuta T, Kobayashi Y, Kawajiri K: Cell density regulates intracellular localization
of aryl hydrocarbon receptor. J Biol Chem 2004, 279:19209–19216.
32. Mayoral R, Fernandez-Martinez A, Roy R, Bosca L, Martin-Sanz P:
Dispensability and dynamics of caveolin-1 during liver regeneration
and in isolated hepatic cells. Hepatology 2007, 46:813–822.
33. Rizzo V, Morton C, DePaola N, Schnitzer JE, Davies PF: Recruitment of
endothelial caveolae into mechanotransduction pathways by flow
conditioning in vitro. Am J Physiol Heart Circ Physiol 2003, 285:H1720–1729.
34. Lajoie P, Nabi IR: Lipid rafts, caveolae, and their endocytosis. Int Rev Cell
Mol Biol 2010, 282:135–163.
35. Bastiani M, Parton RG: Caveolae at a glance. J Cell Sci 2010, 123:3831–3836.
36. Pol A, Martin S, Fernandez MA, Ingelmo-Torres M, Ferguson C, Enrich C, Parton RG:
Cholesterol and fatty acids regulate dynamic caveolin trafficking
through the Golgi complex and between the cell surface and lipid
bodies. Mol Biol Cell 2005, 16:2091–2105.
37. Tanos R, Patel RD, Murray IA, Smith PB, Patterson AD, Perdew GH: Aryl
hydrocarbon receptor regulates the cholesterol biosynthetic pathway ina dioxin response element-independent manner. Hepatology 2012,
55:1994–2004.
38. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 1997,
387:569–572.
39. Castanho MA, Brown W, Prieto MJ: Filipin and its interaction with
cholesterol in aqueous media studied using static and dynamic light
scattering. Biopolymers 1994, 34:447–456.
40. Muller G, Hanekop N, Wied S, Frick W: Cholesterol depletion blocks redistribution
of lipid raft components and insulin-mimetic signaling by glimepiride and
phosphoinositolglycans in rat adipocytes. Mol Med 2002, 8:120–136.
41. Atger VM, de la Llera MM, Stoudt GW, Rodrigueza WV, Phillips MC, Rothblat
GH: Cyclodextrins as catalysts for the removal of cholesterol from
macrophage foam cells. J Clin Invest 1997, 99:773–780.
42. Martin S, Parton RG: Caveolin, cholesterol, and lipid bodies. Semin Cell Dev
Biol 2005, 16:163–174.
43. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB,
Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B,
Lagaud G, Christ GJ, Edelmann W, Lisanti MP: Caveolin-1 null mice are
viable but show evidence of hyperproliferative and vascular
abnormalities. J Biol Chem 2001, 276:38121–38138.
44. Schubert W, Frank PG, Razani B, Park DS, Chow CW, Lisanti MP: Caveolae-deficient
endothelial cells show defects in the uptake and transport of albumin
in vivo. J Biol Chem 2001, 276:48619–48622.
45. Sharma DK, Brown JC, Choudhury A, Peterson TE, Holicky E, Marks DL, Simari R,
Parton RG, Pagano RE: Selective stimulation of caveolar endocytosis by
glycosphingolipids and cholesterol. Mol Biol Cell 2004, 15:3114–3122.
46. Dong B, Cheng W, Li W, Zheng J, Wu D, Matsumura F, Vogel CF: FRET
analysis of protein tyrosine kinase c-Src activation mediated via aryl
hydrocarbon receptor. Biochim Biophys Acta 1810, 2011:427–431.
47. Echarri A, Del Pozo MA: Caveolae internalization regulates integrin-dependent
signaling pathways. Cell Cycle 2006, 5:2179–2182.
48. Allen JA, Yu JZ, Donati RJ, Rasenick MM: Beta-adrenergic receptor
stimulation promotes G alpha s internalization through lipid rafts:
a study in living cells. Mol Pharmacol 2005, 67:1493–1504.
49. Bastiaanse EM, Hold KM, Van der Laarse A: The effect of membrane
cholesterol content on ion transport processes in plasma membranes.
Cardiovasc Res 1997, 33:272–283.
50. Nguyen DH, Espinoza JC, Taub DD: Cellular cholesterol enrichment impairs T
cell activation and chemotaxis. Mech Ageing Dev 2004, 125:641–650.
51. Fernandez-Salguero P, Pineau T, Hilbert DM, McPhail T, Lee SS, Kimura S,
Nebert DW, Rudikoff S, Ward JM, Gonzalez FJ: Immune system impairment
and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor.
Science 1995, 268:722–726.
52. Rico-Leo EM, Alvarez-Barrientos A, Fernandez-Salguero PM: Dioxin Receptor
Expression Inhibits Basal and Transforming Growth Factor beta-induced
Epithelial-to-mesenchymal Transition. J Biol Chem 2013, 288:7841–7856.
53. Santiago-Josefat B, Pozo-Guisado E, Mulero-Navarro S, Fernandez-Salguero PM:
Proteasome inhibition induces nuclear translocation and transcriptional
activation of the dioxin receptor in mouse embryo primary fibroblasts in
the absence of xenobiotics. Mol Cell Biol 2001, 21:1700–1709.
54. Pozo-Guisado E, Lorenzo-Benayas MJ, Fernandez-Salguero PM: Resveratrol
modulates the phosphoinositide 3-kinase pathway through an estrogen
receptor alpha-dependent mechanism: relevance in cell proliferation.
Int J Cancer 2004, 109:167–173.
55. Santiago-Josefat B, Fernandez-Salguero PM: Proteasome inhibition induces
nuclear translocation of the dioxin receptor through an Sp1 and protein
kinase C-dependent pathway. J Mol Biol 2003, 333:249–260.
56. Roman AC, Benitez DA, Carvajal-Gonzalez JM, Fernandez-Salguero PM:
Genome-wide B1 retrotransposon binds the transcription factors dioxin
receptor and Slug and regulates gene expression in vivo. Proc Natl Acad
Sci U S A 2008, 105:1632–1637.
57. Christian AE, Haynes MP, Phillips MC, Rothblat GH: Use of cyclodextrins for
manipulating cellular cholesterol content. J Lipid Res 1997, 38:2264–2272.
58. Yumoto R, Suzuka S, Oda K, Nagai J, Takano M: Endocytic uptake of
FITC-albumin by human alveolar epithelial cell line A549. Drug Metab
Pharmacokinet 2012, 27:336–343.
doi:10.1186/s12964-014-0057-7
Cite this article as: Rey-Barroso et al.: The Dioxin receptor modulates
Caveolin-1 mobilization during directional migration: role of cholesterol.
Cell Communication and Signaling 2014 12:57.
